11^th Global Ophthalmology Meeting

Ophthalmogenetics and Gene Therapy

The Ophthalmogenetics and Gene Therapy track focuses on the genetic basis of ocular diseases and the transformative potential of gene-based interventions. This track invites submissions on the identification of genetic mutations responsible for hereditary eye disorders, advancements in gene editing technologies, and the development of gene therapies targeting conditions such as retinitis pigmentosa and choroideremia. Researchers are encouraged to present clinical trial results, novel delivery systems, and the ethical considerations surrounding gene therapy in ophthalmology. By fostering collaboration between geneticists and ophthalmologists, this track aims to enhance understanding and treatment of genetic eye diseases.